CVS Insider Transactions
Transaction Date (SEC Report) |
Reporting Name | Relationship | Shrs. Owned | Type | Acq./Disp. | Shrs. Transacted | Price() | Amount() |
---|---|---|---|---|---|---|---|---|
2024-02-28 | Joyner J. David | officer: EVP&President-PharmacyServices | 40,681 | F-InKind | D | 1,970 | 75.19 | 148,124.00 |
2024-02-28 | COWHEY THOMAS F. | officer: SVP, Interim CFO | 28,631 | F-InKind | D | 5,641 | 75.19 | 424,147.00 |
2024-02-28 | Khichi Samrat S. | officer: EVP, CPO and General Counsel | 9,750 | F-InKind | D | 6,210 | 75.19 | 466,930.00 |
2024-02-26 | Shah Prem S | officer: EVP and Pres-Pharm, Consumer W | 43,185.463 | F-InKind | D | 261 | 76.43 | 19,948.00 |
2024-02-26 | Chaguturu Sreekanth K | officer: EVP and Chief Medical Officer | 9,333.9847 | F-InKind | D | 355 | 76.43 | 27,133.00 |
2024-02-26 | Havanec Laurie P. | officer: EVP and Chief People Officer | 45,183 | F-InKind | D | 6,698 | 76.43 | 511,928.00 |
2024-02-16 | Shah Prem S | officer: EVP and Pres-Pharm, Consumer W | 39,764.7624 | S-Sale | D | 29,473 | 76.95 | 2,267,947.00 |
2024-02-12 | Chaguturu Sreekanth K | officer: EVP and Chief Medical Officer | 8,645.1867 | A-Award | A | 1,926 | 0.00 | 0.00 |
2024-02-12 | Havanec Laurie P. | officer: EVP and Chief People Officer | 37,203 | A-Award | A | 16,817 | 0.00 | 0.00 |
2024-02-12 | Clark James David | officer: SVP, Cont & Chief Acct Officer | 7,150 | A-Award | A | 2,452 | 0.00 | 0.00 |
2024-02-12 | Shah Prem S | officer: EVP and Pres-Pharm, Consumer W | 69,237.7624 | A-Award | A | 13,313 | 0.00 | 0.00 |
2024-02-12 | Lynch Karen S | director, officer: President and CEO | 136,640 | A-Award | A | 136,640 | 0.00 | 0.00 |
2023-12-14 | Clark James David | officer: SVP, Cont & Chief Acct Officer | 8,760 | F-InKind | D | 122 | 68.48 | 8,355.00 |
2023-12-07 | Finucane Anne A. | director | 7,232.2482 | G-Gift | D | 3,450 | 74.28 | 256,266.00 |
2023-11-30 | Kane Brian A | officer: EVP/President, Aetna | 77,017 | A-Award | A | 77,017 | 67.95 | 5,233,305.00 |
2023-11-30 | COWHEY THOMAS F. | officer: SVP, Interim CFO | 60,938 | A-Award | A | 7,358 | 67.95 | 499,976.00 |
2023-11-15 | SCHAPIRO MARY L | director | 17,734.5362 | A-Award | A | 1,817.2284 | 0.00 | 0.00 |
2023-11-15 | MILLON JEAN PIERRE | director | 3,362 | A-Award | A | 1,925 | 69.13 | 133,075.00 |
2023-11-15 | Mahoney Michael F | director | 1,817 | A-Award | A | 1,817 | 69.13 | 125,609.00 |
2023-11-15 | LUDWIG EDWARD J | director | 14,522.672 | A-Award | A | 2,422.97 | 0.00 | 0.00 |
2023-11-15 | KIRBY J SCOTT | director | 2,721 | A-Award | A | 2,422 | 69.13 | 167,433.00 |
2023-11-15 | Finucane Anne A. | director | 10,682.2482 | A-Award | A | 1,925 | 69.13 | 133,075.00 |
2023-11-15 | FARAH ROGER N | director | 29,639.0157 | A-Award | A | 4,411.9774 | 0.00 | 0.00 |
2023-11-15 | DEPARLE NANCY ANN | director | 29,524 | A-Award | A | 1,925 | 69.13 | 133,075.00 |
2023-11-15 | DECOUDREAUX ALECIA A | director | 29,199.6548 | A-Award | A | 1,817.2284 | 0.00 | 0.00 |
2023-11-15 | BROWN C DAVID II | director | 78,483.6818 | A-Award | A | 1,925.7197 | 0.00 | 0.00 |
2023-11-15 | Balser Jeffrey R. | director | 5,093 | A-Award | A | 1,817 | 69.13 | 125,609.00 |
2023-11-15 | AGUIRRE FERNANDO | director | 32,176 | A-Award | A | 1,998 | 69.13 | 138,122.00 |
2023-11-03 | LUDWIG EDWARD J | director | 20,630 | P-Purchase | A | 2,000 | 70.47 | 140,930.00 |
2023-11-01 | Mahoney Michael F | director | 210 | I | 0 | 0.00 | 0.00 | |
2023-11-01 | Mahoney Michael F | director | 175 | D | 0 | 0.00 | 0.00 | |
2023-10-13 | COWHEY THOMAS F. | officer: SVP, Interim CFO | 53,580 | D | 0 | 0.00 | 0.00 | |
2023-10-13 | COWHEY THOMAS F. | officer: SVP, Interim CFO | 14,977 | D | 0 | 0.00 | 0.00 | |
2023-04-01 | COWHEY THOMAS F. | officer: SVP, Interim CFO | 0 | D | 20,790 | 101.09 | 2,101,661.00 | |
2024-04-01 | COWHEY THOMAS F. | officer: SVP, Interim CFO | 0 | D | 33,402 | 74.31 | 2,482,103.00 | |
2023-10-01 | KIRBY J SCOTT | director: | 0 | 0 | 0.00 | 0.00 | ||
2023-10-02 | KIRBY J SCOTT | director | 299 | A-Award | A | 299 | 69.82 | 20,876.00 |
2023-09-01 | Kane Brian A | officer: EVP/President, Aetna | 910 | D | 0 | 0.00 | 0.00 | |
2023-08-31 | Shah Prem S | officer: EVP and Co-President of Retail | 50,987.7242 | F-InKind | D | 3,508 | 65.17 | 228,616.00 |
2023-08-31 | Mandadi Tilak | officer: EVP, Chief Technology Officer | 20,229 | F-InKind | D | 13,053 | 65.17 | 850,664.00 |
2023-08-03 | Clark James David | officer: SVP, Cont & Chief Acct Officer | 27,826 | S-Sale | D | 2,631.255 | 74.79 | 196,792.00 |
2023-08-03 | Clark James David | officer: SVP, Cont & Chief Acct Officer | 4,698 | S-Sale | D | 23,128 | 74.94 | 1,733,212.00 |
2023-05-18 | MILLON JEAN PIERRE | director | 1,437 | A-Award | A | 1,437 | 69.31 | 99,598.00 |
2023-05-18 | Finucane Anne A. | director | 8,757.2482 | A-Award | A | 1,437 | 69.31 | 99,598.00 |
2023-05-18 | DEPARLE NANCY ANN | director | 27,599 | A-Award | A | 1,437 | 69.31 | 99,598.00 |
2023-05-18 | Balser Jeffrey R. | director | 3,276 | A-Award | A | 1,329 | 69.31 | 92,113.00 |
2023-05-18 | AGUIRRE FERNANDO | director | 30,178 | A-Award | A | 1,329 | 69.31 | 92,113.00 |
2023-05-18 | SCHAPIRO MARY L | director | 15,534.0707 | A-Award | A | 1,329.1733 | 0.00 | 0.00 |
2023-05-18 | LUDWIG EDWARD J | director | 11,816.975 | A-Award | A | 2,068.6048 | 0.00 | 0.00 |
2023-05-18 | FARAH ROGER N | director | 24,634.358 | A-Award | A | 3,917.1837 | 0.00 | 0.00 |
2023-05-18 | BROWN C DAVID II | director | 74,674.4498 | A-Award | A | 1,437.3828 | 0.00 | 0.00 |
2023-05-18 | DECOUDREAUX ALECIA A | director | 26,715.372 | A-Award | A | 1,329.1733 | 0.00 | 0.00 |
2023-05-03 | Lynch Karen S | director, officer: President and CEO | 431,392 | P-Purchase | A | 14,000 | 69.75 | 976,567.00 |
2023-04-01 | Shah Prem S | officer: EVP and Co-President of Retail | 89,073 | A-Award | A | 89,073 | 74.31 | 6,619,015.00 |
2023-04-01 | Shah Prem S | officer: EVP and Co-President of Retail | 49,364.3199 | F-InKind | D | 3,221 | 74.31 | 239,353.00 |
2023-04-01 | PELUSO MICHELLE A | officer: EVP and Co-President of Retail | 124,383 | F-InKind | D | 98,299 | 74.31 | 7,304,599.00 |
2023-04-01 | PELUSO MICHELLE A | officer: EVP and Co-President of Retail | 89,073 | A-Award | A | 89,073 | 74.31 | 6,619,015.00 |
2023-04-01 | Mandadi Tilak | officer: EVP, Chief Technology Officer | 96,496 | A-Award | A | 96,496 | 74.31 | 7,170,618.00 |
2023-04-01 | Lynch Karen S | director, officer: President and CEO | 244,952 | A-Award | A | 244,952 | 74.31 | 18,202,383.00 |
2023-04-01 | Lynch Karen S | director, officer: President and CEO | 112,933 | F-InKind | D | 93,677 | 74.31 | 6,961,138.00 |
2023-04-01 | Khichi Samrat S. | officer: EVP, CPO and General Counsel | 66,805 | A-Award | A | 66,805 | 74.31 | 4,964,280.00 |
2023-04-01 | Joyner J. David | officer: EVP&President-PharmacyServices | 51,959 | A-Award | A | 51,959 | 74.31 | 3,861,073.00 |
2023-04-01 | Havanec Laurie P. | officer: EVP and Chief People Officer | 51,959 | A-Award | A | 51,959 | 74.31 | 3,861,073.00 |
2023-04-01 | GUERTIN SHAWN M | officer: EVP & Chief Financial Officer | 148,456 | A-Award | A | 148,456 | 74.31 | 11,031,765.00 |
2023-04-01 | Finke Daniel P | officer: EVP/Pres, Health Care Benefits | 74,228 | A-Award | A | 74,228 | 74.31 | 5,515,883.00 |
2023-04-01 | Finke Daniel P | officer: EVP/Pres, Health Care Benefits | 35,067.8088 | F-InKind | D | 3,856 | 74.31 | 286,539.00 |
2023-04-01 | Clark James David | officer: SVP, Cont & Chief Acct Officer | 30,457.2554 | F-InKind | D | 1,471 | 74.31 | 109,310.00 |
2023-04-01 | Clark James David | officer: SVP, Cont & Chief Acct Officer | 9,649 | A-Award | A | 9,649 | 74.31 | 717,017.00 |
2023-04-01 | Clark James David | officer: SVP, Cont & Chief Acct Officer | 9,080 | A-Award | A | 2,186 | 74.31 | 162,442.00 |
2023-04-01 | Chaguturu Sreekanth K | officer: EVP and Chief Medical Officer | 40,825 | A-Award | A | 40,825 | 74.31 | 3,033,706.00 |
2023-04-01 | Chaguturu Sreekanth K | officer: EVP and Chief Medical Officer | 6,427.6327 | F-InKind | D | 1,854 | 74.31 | 137,771.00 |
2023-02-27 | Shah Prem S | officer: EVP and Co-President of Retail | 44,403.3199 | F-InKind | D | 226 | 85.77 | 19,384.00 |
2023-02-27 | PELUSO MICHELLE A | officer: EVP and Co-President of Retail | 222,682 | F-InKind | D | 12,304 | 85.77 | 1,055,314.00 |
2023-02-28 | Khichi Samrat S. | officer: EVP, CPO and General Counsel | 47,881 | A-Award | A | 47,881 | 83.54 | 3,999,979.00 |
2023-02-28 | Joyner J. David | officer: EVP&President-PharmacyServices | 23,940 | A-Award | A | 23,940 | 83.54 | 1,999,948.00 |
2023-02-27 | Havanec Laurie P. | officer: EVP and Chief People Officer | 20,386 | F-InKind | D | 4,046 | 85.77 | 347,025.00 |
2023-02-28 | Clark James David | officer: SVP, Cont & Chief Acct Officer | 26,151.2554 | F-InKind | D | 179 | 83.54 | 14,954.00 |
2023-02-28 | Chaguturu Sreekanth K | officer: EVP and Chief Medical Officer | 4,105.6327 | F-InKind | D | 120 | 83.54 | 10,025.00 |
2023-02-27 | Chaguturu Sreekanth K | officer: EVP and Chief Medical Officer | 3,871.6327 | F-InKind | D | 318 | 85.77 | 27,275.00 |
2023-02-13 | Khichi Samrat S. | officer | 0 | 0 | 0.00 | 0.00 | ||
2023-02-02 | PELUSO MICHELLE A | officer: EVP and Co-President of Retail | 207,465 | A-Award | A | 192,554 | 0.00 | 0.00 |
2023-01-30 | Joyner J. David | officer: EVP&President-PharmacyServices | 34,672 | D | 0 | 0.00 | 0.00 | |
2023-02-02 | Lynch Karen S | director, officer: President and CEO | 206,610 | A-Award | A | 206,610 | 0.00 | 0.00 |
2022-12-31 | Moriarty Thomas M | officer: EVP & General Counsel | 315,273.0221 | F-InKind | D | 292,856 | 93.19 | 27,291,251.00 |
2022-12-15 | Moriarty Thomas M | officer: EVP & General Counsel | 709,105.0221 | M-Exempt | A | 100,976 | 78.05 | 7,881,177.00 |
2022-12-15 | Moriarty Thomas M | officer: EVP & General Counsel | 644,619.0221 | M-Exempt | A | 36,490 | 62.21 | 2,270,043.00 |
2022-12-15 | Moriarty Thomas M | officer: EVP & General Counsel | 608,129.0221 | S-Sale | D | 36,490 | 98.24 | 3,584,869.00 |
2022-12-15 | Moriarty Thomas M | officer: EVP & General Counsel | 24,248 | M-Exempt | D | 100,976 | 0.00 | 0.00 |
2022-12-15 | Moriarty Thomas M | officer: EVP & General Counsel | 0 | M-Exempt | D | 36,490 | 0.00 | 0.00 |
2022-12-01 | Clark James David | officer: SVP, Cont & Chief Acct Officer | 26,177.2554 | F-InKind | D | 153 | 101.65 | 15,552.00 |
2022-11-29 | Chaguturu Sreekanth K | officer: EVP and Chief Medical Officer | 2,896.7803 | F-InKind | D | 442 | 100.88 | 44,589.00 |
2022-11-17 | WELDON WILLIAM C | director | 41,834.4566 | A-Award | A | 1,764.458 | 94.93 | 167,500.00 |
2022-11-17 | SCHAPIRO MARY L | director | 14,107.3441 | A-Award | A | 1,764.458 | 94.93 | 167,500.00 |
2022-11-17 | MILLON JEAN PIERRE | director | 2,811 | A-Award | A | 1,402 | 94.93 | 133,092.00 |
2022-11-17 | Finucane Anne A. | director | 7,320.2482 | A-Award | A | 1,428 | 94.93 | 135,560.00 |
2022-11-17 | FARAH ROGER N | director | 20,574.897 | A-Award | A | 3,212.8937 | 94.93 | 305,000.00 |
2022-11-17 | DEPARLE NANCY ANN | director | 26,162 | A-Award | A | 1,402 | 94.93 | 133,092.00 |
2022-11-17 | DECOUDREAUX ALECIA A | director | 25,211.8568 | A-Award | A | 1,323.3435 | 94.93 | 125,625.00 |
2022-11-17 | BROWN C DAVID II | director | 72,734.1051 | A-Award | A | 1,402.3491 | 94.93 | 133,125.00 |
2022-11-17 | Balser Jeffrey R. | director | 1,947 | A-Award | A | 1,323 | 94.93 | 125,592.00 |
Disclaimer: The data contained in this website is not necessarily real-time nor accurate. All derived (stocks, indexes, futures) and Forex prices are not provided by exchanges but rather by our third party API www.financialmodellingprep.com, and so prices may not be accurate and may differ from the actual market price, meaning prices are indicative and not appropriate for trading purposes. Therefore, Discounting Cash Flows Inc. doesn't bear any responsibility for any trading losses you might incur as a result of using this data. Discounting Cash Flows Inc. or anyone involved with Discounting Cash Flows Inc. will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible.